Accelerated development and manufacturing processes have become pivotal since the onset of the COVID-19 pandemic. Threats of drug shortages have drawn attention to the importance of productivity in the drug development process, alongside the underlying pressure to ensure rapid vaccine and therapeutic production to combat COVID-19 itself. Moving from one CDMO partner to another at different stages of drug development can be a potential cause of delays. Tech transfers can be a key moment where issues can arise, but they can be necessary if you need to find a new partner to help properly scale your project.
Establishing a relationship with a partner who has the right equipment, scientific expertise, and project management skills is crucial to mitigating risk in tech transfers—and ultimately controlling costs. How do you know your new vendor will help solve problems instead of creating more?
View this webinar to gain key insights into how best to mitigate risk in tech transfer, including how to find the best partner for your molecule.
Key Learning Objectives:
- Signals to watch for to indicate you may need to tech transfer
- How to find the right CDMO partner to handle your tech transfer
- How to mitigate risk, reduce cost, and avoid rework when transferring your project